Neutralization of SARS-CoV-2 Variants in Transplant Recipients After Two and Three Doses of mRNA-1273 Vaccine
-
- Deepali Kumar
- University Health Network, Toronto, Ontario, Canada (D.K., V.H.F., V.G.H., T.K., M.I., B.M., G.T., A.H.)
-
- Victor H. Ferreira
- University Health Network, Toronto, Ontario, Canada (D.K., V.H.F., V.G.H., T.K., M.I., B.M., G.T., A.H.)
-
- Victoria G. Hall
- University Health Network, Toronto, Ontario, Canada (D.K., V.H.F., V.G.H., T.K., M.I., B.M., G.T., A.H.)
-
- Queenie Hu
- Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Sinai Health, Toronto, Ontario, Canada (Q.H.)
-
- Reuben Samson
- Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Sinai Health, and Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada (R.S., A.G.).
-
- Terrance Ku
- University Health Network, Toronto, Ontario, Canada (D.K., V.H.F., V.G.H., T.K., M.I., B.M., G.T., A.H.)
-
- Matthew Ierullo
- University Health Network, Toronto, Ontario, Canada (D.K., V.H.F., V.G.H., T.K., M.I., B.M., G.T., A.H.)
-
- Beata Majchrzak-Kita
- University Health Network, Toronto, Ontario, Canada (D.K., V.H.F., V.G.H., T.K., M.I., B.M., G.T., A.H.)
-
- George Tomlinson
- University Health Network, Toronto, Ontario, Canada (D.K., V.H.F., V.G.H., T.K., M.I., B.M., G.T., A.H.)
-
- Anne-Claude Gingras
- Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Sinai Health, and Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada (R.S., A.G.).
-
- Atul Humar
- University Health Network, Toronto, Ontario, Canada (D.K., V.H.F., V.G.H., T.K., M.I., B.M., G.T., A.H.)
Bibliographic Information
- Other Title
-
- Secondary Analysis of a Randomized Trial
Journal
-
- Annals of Internal Medicine
-
Annals of Internal Medicine 175 (2), 226-233, 2022-02
American College of Physicians
- Tweet
Details 詳細情報について
-
- CRID
- 1360861711981156352
-
- DOI
- 10.7326/m21-3480
-
- ISSN
- 15393704
- 00034819
-
- Data Source
-
- Crossref